CFY 196Alternative Names: CFY-196; ColdSol
Latest Information Update: 17 Nov 2010
At a glance
- Originator Perlan Therapeutics
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunostimulants; Intercellular adhesion molecule 1 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Common cold